← Leaderboards
Mark Denton McKee
University Of Chicago
$649,620
Attributed
$649,620
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $129.9K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$649,620 · 1
By mechanism
K08$649,620 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Michael I Nishimura$19,220,002
- Richard L Schilsky$24,946,699
- Hans Schreiber$12,391,832
- David J. Grdina$4,132,498
- Thomas Krausz$2,914,404
Others in their field
Top investigators on “Neoplasm /Cancer Immunotherapy”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Charles A Coltman · Southwest Oncology Group$65,041,418
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Samuel A Wells · Duke University$32,148,803
- George Wilding · University Of Wisconsin Madison$22,104,400
Research focus
Neoplasm /Cancer ImmunotherapyT Cell ReceptorLaboratory MouseTransfection /Expression VectorProtein Quantitation /DetectionAdenocarcinomaT LymphocyteMolecular Assembly /Self AssemblyNeoplasm /CancerBioengineering /Biomedical EngineeringRecombinant DnaBiological ModelsNonhuman Therapy EvaluationProtein StructureNucleic Acid SequenceMolecular CloningHuman TissueMhc Class I AntigenGene TherapyGene Delivery SystemClinical ResearchGenetically Modified AnimalsCarcinoembryonal AntigenFusion Gene
Grant awards (5)
CEA directed cancer treatment with gene-modified T cells$129,924
K08 · FY2007 · CA · contact PI
CEA directed cancer treatment with gene-modified T cells$129,924
K08 · FY2006 · CA · contact PI
CEA directed cancer treatment with gene-modified T cells$129,924
K08 · FY2005 · CA
CEA directed cancer treatment with gene-modified T cells$129,924
K08 · FY2004 · CA
CEA directed cancer treatment with gene-modified T cells$129,924
K08 · FY2003 · CA